Introduction: Who Should Undergo Diagnostics

Aplastic anaemia is not a condition that announces itself loudly at first. Many people don’t notice anything wrong in the early stages because symptoms can develop slowly over weeks or months. This slow progression makes it easy to confuse the signs with less serious illnesses like a common cold or the flu. However, when symptoms do appear, they often reflect the body’s struggle to produce enough blood cells to function properly.^[1][2]

If you or someone you know has been feeling unusually tired for several weeks, experiencing frequent infections that last longer than usual, or noticing unexplained bruising or bleeding that doesn’t seem to stop easily, it’s time to speak with a healthcare provider. These symptoms can indicate that your bone marrow is not making enough red blood cells (which carry oxygen), white blood cells (which fight infections), or platelets (which help blood to clot). When all three types of blood cells drop to dangerously low levels—a condition called pancytopenia—the body struggles to keep up with basic functions.^[2][9]

Sometimes aplastic anaemia symptoms can appear suddenly and be severe right from the start. In these cases, people may feel extremely weak, develop high fevers, or experience heavy bleeding. This is a medical emergency that requires immediate hospitalisation. However, in many cases, the condition develops gradually, giving people time to seek medical advice if they recognise the warning signs early.^[1][12]

People with certain risk factors should be especially alert. Those who have been exposed to high doses of radiation, certain chemicals like benzene or arsenic, or who have undergone chemotherapy or radiation therapy for cancer are at higher risk. Viral infections such as Epstein-Barr virus, cytomegalovirus, parvovirus B19, or HIV can also trigger the condition. Additionally, people with autoimmune diseases like lupus, or those with a family history of inherited bone marrow failure syndromes such as Fanconi anaemia, should be particularly vigilant about any unusual symptoms.^[2][9]

Diagnostic Methods

Diagnosing aplastic anaemia involves a series of tests designed to measure how well your bone marrow is working and to rule out other conditions that might cause similar symptoms. The process typically begins with a visit to your doctor, who will ask detailed questions about your medical history, any medications you’re taking, your work environment, and whether you’ve been exposed to harmful chemicals or had recent viral infections. Your doctor will also want to know if anyone in your family has had blood disorders or inherited conditions affecting the bone marrow.^[7][8]

After taking your history, your doctor will perform a physical examination. They will look for signs of anaemia, such as pale skin, and check for unusual bruising, bleeding, or rashes. They may also listen to your heart to detect a rapid or irregular heartbeat, which can happen when the body doesn’t have enough red blood cells to deliver oxygen efficiently.^[1][8]

Blood Tests

The first major step in diagnosing aplastic anaemia is a set of blood tests. These tests measure the levels of different types of blood cells circulating in your bloodstream. The most common blood test is called a complete blood count (CBC) with differential. This test counts red blood cells, white blood cells, and platelets, and also examines the different types of white blood cells in detail. In aplastic anaemia, all three blood cell types are typically lower than normal, a hallmark sign of the condition.^[2][8]

Another important blood test is the reticulocyte count. Reticulocytes are immature red blood cells that the bone marrow releases into the bloodstream. A healthy bone marrow constantly produces these young cells to replace older red blood cells that have died. In aplastic anaemia, the reticulocyte count is abnormally low because the bone marrow isn’t producing enough new cells.^[2][9]

Doctors may also order a peripheral blood smear, where a sample of your blood is examined under a microscope. This allows a medical pathologist to look closely at the size, shape, and appearance of your blood cells and platelets. Even though aplastic anaemia reduces the number of blood cells, the cells that are present usually look normal under the microscope. This helps doctors distinguish aplastic anaemia from other blood disorders where the cells themselves are abnormal.^[2][9]

Bone Marrow Biopsy

While blood tests provide important clues, they cannot confirm a diagnosis of aplastic anaemia on their own. The definitive test is a bone marrow biopsy. This procedure involves inserting a needle into a large bone, usually the hipbone, to remove a small sample of bone marrow. The sample is then examined under a microscope by a specialist.^[7][8]

In a healthy person, bone marrow is packed with stem cells—the “mother cells” that develop into red blood cells, white blood cells, and platelets. Normally, 30 to 70 percent of the bone marrow is made up of these blood stem cells. In someone with aplastic anaemia, the bone marrow contains very few blood cells. Instead, the marrow is mostly filled with fat. This dramatic reduction in stem cells is what prevents the body from producing enough new blood cells.^[6][7]

The bone marrow biopsy is essential not only for confirming aplastic anaemia but also for ruling out other blood-related diseases that can cause similar symptoms, such as leukaemia or myelodysplastic syndromes. The procedure is usually done under local anaesthesia to minimise discomfort, and while it may sound intimidating, it is generally safe and well-tolerated.^[8]

Additional Diagnostic Tests

Once aplastic anaemia is confirmed, doctors often order additional tests to try to determine the underlying cause. These tests might include genetic testing to check for inherited bone marrow failure syndromes like Fanconi anaemia, dyskeratosis congenita, or Shwachman-Diamond syndrome. Genetic tests can help identify whether the condition is inherited or acquired, which can influence treatment decisions.^[2][9]

Doctors may also test for viral infections that are known to trigger aplastic anaemia, such as Epstein-Barr virus, cytomegalovirus, parvovirus B19, or HIV. Blood tests can detect antibodies or viral particles that indicate a recent or ongoing infection. Additionally, doctors will review your medication history and ask about exposure to environmental toxins like pesticides, benzene, or radiation.^[2][9]

In some cases, doctors may need to perform imaging tests to check for complications. For example, if there’s concern about bleeding in the brain or other organs, a CT scan or MRI might be ordered. These imaging tests can help doctors monitor for serious complications and guide treatment decisions.^[8]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to see if they are safe and effective. For people with aplastic anaemia, participating in a clinical trial can provide access to cutting-edge therapies that are not yet widely available. However, not everyone qualifies for every clinical trial. Researchers use specific diagnostic tests and criteria to ensure that participants meet the requirements of the study.^[11]

To qualify for a clinical trial, patients typically need to undergo the same core diagnostic tests used to diagnose aplastic anaemia in the first place: a complete blood count (CBC) with differential, reticulocyte count, peripheral blood smear, and bone marrow biopsy. These tests confirm the diagnosis and measure the severity of the disease. Clinical trials often categorise patients based on whether they have mild, moderate, or severe aplastic anaemia, as determined by blood cell counts.^[2][9]

Blood cell counts are especially important for clinical trial eligibility. Researchers may look for specific thresholds, such as a red blood cell count below a certain level, a white blood cell count (particularly neutrophils) below a certain number, or a platelet count that falls below a defined limit. These measurements help researchers understand how advanced the disease is and whether a particular treatment is likely to be effective.^[11]

Genetic testing may also be required for some clinical trials, particularly those focused on inherited forms of aplastic anaemia or trials testing therapies that target specific genetic mutations. If a trial is testing a treatment for Fanconi anaemia, for example, participants would need to have genetic testing to confirm they carry the mutation associated with that condition.^[2][9]

In addition to diagnostic tests, clinical trials often require patients to meet certain health criteria. For example, some trials may exclude patients who have severe infections, heart problems, or other serious medical conditions that could interfere with the study or put the patient at additional risk. Doctors will carefully review your overall health, medical history, and current medications to determine if a particular trial is a good fit for you.^[11]

It’s also common for clinical trials to require baseline imaging tests or additional blood tests to monitor how the disease is affecting the body and to track changes over time. For example, a trial might require a chest X-ray or echocardiogram to check heart and lung function before treatment begins. These tests establish a starting point so researchers can measure whether the treatment is working as expected.^[11]

Throughout the course of a clinical trial, participants will continue to undergo regular diagnostic tests to monitor their progress. This might include repeated blood tests every few weeks, periodic bone marrow biopsies, and other assessments to check for side effects or complications. This ongoing monitoring ensures that the treatment is safe and allows researchers to gather valuable data about how well the therapy works.^[11]